摘要
目的探讨痰热清联合阿奇霉素治疗小儿肺炎支原体肺炎(MPP)的临床疗效,并进行对比分析。方法将100例MPP患儿随机分为观察组和对照组各50例,两组均采用阿奇霉素序贯疗法治疗,观察组在阿奇霉素序贯治疗基础上加用痰热清注射液静脉滴注辅助治疗,疗程为2周。同时检测治疗前、治疗后血清中CRP和Ig的含量,观察治疗后两组的临床疗效及随访3个月的复发情况。结果观察组和对照组总有效率分别为100%和80%,观察组疗效明显优于对照组(P<0.05);在治疗前两组血清CRP和Ig水平差异无统计学意义,治疗3周后两组比较,差异有统计学意义(P<0.05),观察组复发率明显低于对照组(P<0.05)。结论痰热清联合阿奇霉素序贯疗法治疗小儿MPP疗效显著、复发率低,值得临床推广应用。
Objective To investigate the clinical effect of Tanreqing combined with Azithromycin in the treatment of mycoplasma pneumoniae pneumonia（MPP） in children,and to make clinical comparative analysis.Methods One hundred cases of MMP children were randomly divided into observation group and control group,each group had 50 cases.The two groups were all given Azithromycin sequential therapy,while on the basis of Azithromycin therapy,the observation group was given Tanreqing injecta adjuvant therapy for two weeks.The content of serum CRP and Ig were detected before and after treatment,and the clinical effect and recurrence condition after three months follow-up were observed.Results The total effective rate of the observation group and the control group was 100% and 80% respectively,the curative effect of observation group was better than that of the control group（P 0.05）.Before treatment the levels of serum CRP and Ig of the two groups had no significant differences,while 3 weeks after treatment the differences were significant（P 0.05）.The recurrence rate of the observation group was significantly lower than that of the control group（P 0.05）.Conclusion The curative effect of Tanreqing combined with Azithromycin sequential therapy in the treatment of MMP in children is significant and the recurrence rate is low,which is worthy of clinical application.
出处
《中国当代医药》
2012年第11期71-72,共2页
China Modern Medicine
关键词
肺炎支原体肺炎
痰热清
阿奇霉素
序贯疗法
Mycoplasma pneumoniae pneumonia
Tanreqing
Azithromycin
Sequential therapy
